ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up
February 01, 2021 08:30 ET
|
ProPhase Labs, Inc.
Company to Host Business Update Shareholder’s Conference Call on February 10, 2021 at 11:00 a.m. Eastern Time GARDEN CITY, NY, Feb. 01, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:...
ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
January 29, 2021 08:30 ET
|
ProPhase Labs, Inc.
- Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day – GARDEN CITY, NY, Jan. 29, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical...
ProPhase Labs, Inc. Announces Closing of Public Offering
January 21, 2021 16:30 ET
|
ProPhase Labs, Inc.
Garden City, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced...
ProPhase Labs Announces Proposed Public Offering of Common Stock
January 15, 2021 17:21 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has commenced a proposed...
ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
January 05, 2021 12:10 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has entered into a definitive...
ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020
November 16, 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 16, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced net sales of $3.8 million for...
ProPhase Labs Completes Acquisition of CLIA Accredited Lab and Provides Corporate Update
November 02, 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 02, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has completed the...
ProPhase Labs Engages Industry Expert to Advise on Possible Acquisition of CLIA Accredited Labs Certified for COVID-19 and Other Testing
September 30, 2020 17:04 ET
|
ProPhase Labs, Inc.
Company Enters into Consulting Agreement and Amended and Restated Promissory Note and Security Agreement with Predictive Laboratories, Inc. to Further These Plans DOYLESTOWN, Pennsylvania, Sept. 30,...
ProPhase Labs Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
September 30, 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Sept. 30, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, has engaged international investor relations...
ProPhase Labs Announces At-The-Market Equity Facility
September 23, 2020 16:10 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Sept. 23, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced that it has entered into an at-the-market (“ATM”) equity...